Female cognitive survey of cervical cancer prevention: over half of the interviewees do not understand HPV high -risk types

Cover Journalist Ning Zhi

Recently, the "Cervical Cancer Prevention and HPV Vaccine Cognitive Research Results" (hereinafter referred to as "Research Results"), directed by the Chinese Maternal and Child Health Association, was officially released. The survey came from 4,393 women agents 16-45 years old.

The survey results show that only 30 % of the interviewed women know and act on cervical cancer first and second -level prevention and regular cervical cancer screening. More than half of the respondents do not understand HPV high -risk types. In addition, the interviewed women's willingness to inoculate HPV vaccine and take their daughter inoculation is high, but due to subjective factors such as price and safety, the affected and supply restrictions, and the vaccine waiting phenomenon is not a minority.

The women interviewed lack of HPV -related cognition

The results of the survey show that 95%of the respondents have heard of HPV, which is human papilloma virus, but 55%of women interviewed cannot accurately identify common high -risk types.

In this regard, Zhao Yan, deputy chief physician of the Gynecology Department of Peking University People's Hospital, explained: "There are more than 200 types of HPVs that have been determined at present. Depending on the carcinogenicity, HPV is divided into high -risk and low -risk types, while high -risk HPVs This is the "culprit" that leads to cervical cancer. There are 14 types of high -risk HPV known in which HPV16 and 18 are the most important high -risk. High-risk HPV infection is presented as two peaks. The first peak age is 15-24 years old, and the second infection peak age is over 40 years old. Before the peak of the infection is approaching, the HPV vaccine will be vaccinated as soon as possible. "

Waiting for the price of the attachment, or the important reason for the low vaccination rate

At present, there are 5 HPV vaccines in my country in China, including imported two-price, four-valent, nine-prices, and two domestic two-prices. The "Research Results" shows that only 30%of the interviewed women have vaccinated HPV vaccines. Regarding the reasons for the unlimed HPV vaccine, 54%of the interviewed women said that they were not vaccinated because they were not vaccinated because they were not involved in the HPV vaccine because they were waiting for high prices.

In this regard, Wang Linhong, Honorary Chairman of the Women's Health Branch of the Chinese Prevention Medical Association, suggested: "Don't wait blindly. Women can flexibly choose according to the vaccine resources and their own economic conditions. The sooner the HPV vaccine, the better!"

Regarding the question of whether the HPV vaccine needs to "change" or "strengthen the needle", Wang Linhong emphasized that the mathematical model of clinical data predicts the long -term protection effect of the HPV vaccine, and the protection time can be up to 50 years. In addition, the industry authoritative agencies do not recommend reinforcing HPV vaccines. In the current situation of HPV vaccine supply, it is more important to take vaccination as high as high.

Chengdu has launched the city in the city in 2021, HPV vaccination work in school -age girls

Best vaccination time: first 9-14 years old, followed by the moment

Regardless of whether there is a daughter, about 92%of the interviewed women expressed their willingness to take positive vaccination. Even so, 61%of the women interviewed were not aware of the age of 9-14 as the best age of vaccination.

Zhao Yan said that when girls are in the best age, parents should pay attention to the opportunity of vaccination. The earlier, the smaller the better, the better. The application object of my country's HPV vaccine is a 9-45-year-old woman. Even if you miss an adult woman who is 9-14 years old, the HPV vaccine can still benefit. The second best age of vaccination is the present. In addition, all HPV vaccines currently on the market cannot cover all high -risk HPVs, that is, the protection rate is not 100%. After vaccination of HPV vaccines, it is necessary to pay attention to regular screening to better prevent cervical cancer.

- END -